Investors and Media

Press Releases

May 27, 2020

Scholar Rock to Present at the Jefferies Virtual Global Healthcare Conference

May 21, 2020

Scholar Rock Appoints Tony Kingsley to Its Board of Directors

May 18, 2020

Scholar Rock Presents Baseline Demographics Data from the SRK-015 TOPAZ Trial at the American Academy of Neurology Conference

May 7, 2020

Scholar Rock Reports First Quarter 2020 Financial Results and Highlights Business Progress

May 5, 2020

Scholar Rock Announces Initiation of Patient Dosing in Phase 1 Proof-of-Concept Immuno-Oncology Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy

April 9, 2020

Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Antibodies that Modulate TGFβ Activation

March 26, 2020

Scholar Rock Announces Publication in Science Translational Medicine of Preclinical Data Detailing a Potent and Selective Inhibitor of TGFβ1 Overcoming Primary Resistance to Checkpoint Inhibition

March 24, 2020

Scholar Rock Presents Data for SRK-015 at the Muscular Dystrophy Association Clinical and Scientific Conference

Archived Press Releases